Page last updated: 2024-08-23

ursodeoxycholic acid and Hypertension, Pulmonary

ursodeoxycholic acid has been researched along with Hypertension, Pulmonary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Amuro, H; Ito, T; Nishizawa, T; Nomura, S; Ozaki, Y; Son, Y; Tamaki, T; Tanaka, A	1

Other Studies

1 other study(ies) available for ursodeoxycholic acid and Hypertension, Pulmonary

Article	Year
Combined use of ursodeoxycholic acid and bosentan prevents liver toxicity caused by endothelin receptor antagonist bosentan monotherapy: two case reports. Journal of medical case reports, 2014, Jul-11, Volume: 8 Topics: Aged; Bosentan; Chemical and Drug Induced Liver Injury; Cholagogues and Choleretics; Drug Therapy, Combination; Endothelin Receptor Antagonists; Female; Humans; Hypertension, Pulmonary; Liver Function Tests; Middle Aged; Sulfonamides; Ursodeoxycholic Acid	2014

Article

Year

Combined use of ursodeoxycholic acid and bosentan prevents liver toxicity caused by endothelin receptor antagonist bosentan monotherapy: two case reports.

Journal of medical case reports, 2014, Jul-11, Volume: 8

Topics: Aged; Bosentan; Chemical and Drug Induced Liver Injury; Cholagogues and Choleretics; Drug Therapy, Combination; Endothelin Receptor Antagonists; Female; Humans; Hypertension, Pulmonary; Liver Function Tests; Middle Aged; Sulfonamides; Ursodeoxycholic Acid

2014